MedPath

X-ray Dose Reduction in Electrophysiology

Not Applicable
Completed
Conditions
Arrhythmias, Cardiac
Interventions
Radiation: Regular image processing
Radiation: Advanced image processing
Registration Number
NCT01593852
Lead Sponsor
Philips Clinical & Medical Affairs Global
Brief Summary

Allura Clarity is a novel X-ray imaging technology, that combines advanced real-time image noise reduction algorithms, with state-of-the-art hardware to reduce patient entrance dose significantly. This is realized by anatomy-specific optimization of the full acquisition chain (grid switch, beam filtering, pulse width, spot size, detector and image processing engine) for every clinical task individually. Furthermore, smaller focal spot sizes and shorter pulses are used, which are known to positively influence image quality .

The primary aim of this study is to verify if a significant reduction in total procedural X-ray dose during electrophysiological interventions can be achieved by using advanced image processing (Allura Clarity).

Detailed Description

X-ray dose and image quality are related by laws of physics. Low dose and high image quality cannot be achieved at the same time. However, image processing algorithms can help an x-ray system to acquire images with lower dose without influencing image quality or achieving higher image quality with equal dose.

In order to introduce a dose reduction technology the most important aspect is to validate the diagnostic image information. Philips has developed a new algorithm that is capable to process images with similar image quality but acquired at lower dose.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
136
Inclusion Criteria
  • Patients with heart rhythm disturbances undergoing an interventional treatment for their heart rhythm disturbance
  • Patients who are allowed, able, willing to and have provided informed consent
  • Patients to be treated with ablation for atrial fibrillation (paroxysmal, persistent or permanent), atypical atrial flutter or patients to be treated with ablation for ischemic or non-ischemic ventricular tachycardia
  • Patients who are treated in heart catheterization room 5 (HCK5) of the Catherina Hospital
Exclusion Criteria
  • Patients under 18 years of age.
  • Patient who are pregnant or breast feeding.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Regular X-ray dose settingsRegular image processingFor patients in this group x-ray images are acquired with regular dose settings of the x-ray system and regular image processing
Reduced X-ray dose settingsAdvanced image processingFor patients in this group x-ray images are acquired with reduced dose settings of the x-ray system and advanced image processing
Primary Outcome Measures
NameTimeMethod
Cumulative Dose Area Product (DAP) ValueDay 0

Percentage reduction of reduced X-ray dose settings (Allura Clarity) vs. regular X-ray dose settings (AlluraXper) in DAP.

Cumulative Air Kerma (AK) ValueDay 0

Percentage reduction of reducted X-ray dose settings (Allura Clarity) vs. regular X-ray dose settings (AlluraXper) in AK.

Secondary Outcome Measures
NameTimeMethod
Serious Adverse EventsDay 0 if any
Staff Dose Measured by DoseAware and Electronic Personal Dosimeter (EPD)Day 0

Staff dose measured by Electronic Personal Dosimeter (EPD) worn by the operator over the lead apron (EPD operator) and the other mounted at a fixed location in the EP laboratory (EPD fixed)

Usage of Physician Controlled Dose SettingsDay 0

In both groups, default fluoroscopy dose settings were 'low', but could be changed by the operator to a medium or high setting for better imaging. The necessity to increase fluoroscopy dose for better imaging to medium or high was registered as a percentage of total number of fluoroscopy frames.

Physician Professional Judgment on Procedural SuccessDay 0

Measurement of professional judgment (yes/no) of the treating physician.

Physician Professional Judgment on Adequacy of Images for Performing the EP ProcedureDay 0

If fluoroscopy time (see results in other secondary outcomes), number of exposure frames (see below) and procedure duration (see results in other secondary outcomes) are equivalent between the two groups, this will indicate that image quality (IQ) is equally adequate in both groups.

Procedure DurationDay 0
Fluoroscopy TimeDay 0

Trial Locations

Locations (1)

Catharina Ziekenhuis

🇳🇱

Eindhoven, Netherlands

© Copyright 2025. All Rights Reserved by MedPath